3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
6
Phase NA
4
Phase 3
4
Phase EARLY_PHASE1
1
Phase 4
1
Phase 2/3
1
Status
Completed
4
Unknown
1
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Vitamin D Deficiency
1
Renal Insufficiency, Chronic
1
Neoplasms
1
Cardiovascular Diseases
1
Bone Diseases, Metabolic
1
Anemia
1
Interventions
Saline Solution
6
Letrozole
6
Fentanyl
6
Sodium Chloride
5
Dexamethasone
5
Pregabalin
4
Ketamine
4
Goserelin
4
Gemcitabine
4
Bevacizumab
4
Tranexamic Acid
3
Photochemotherapy
3
Pemetrexed
3
Paclitaxel
3
Metformin
3
Leuprolide
3
Docetaxel
3
Cyclophosphamide
3
Carboplatin
3
Capecitabine
3
Acetaminophen
3
ulipristal acetate
2
sodium glycididazole
2
nilotinib
2
liposomal doxorubicin
2
human papillomavirus vaccine, L1 type 16, 18
2
flurbiprofen axetil
2
fludarabine
2
fluciclovine F-18
2
epoetin beta
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Terminated
×
Cholecalciferol
×
Clear all
NCT01817699
2019-02-04
CANDLE-KIT
CANDLE-KIT Trial Study Group
Phase 4
Terminated
161 enrolled